98%
921
2 minutes
20
Background: The high-activity adenine base editors (ABEs), engineered with the recently-developed tRNA adenosine deaminases (TadA8e and TadA9), show robust base editing activity but raise concerns about off-target effects.
Results: In this study, we perform a comprehensive evaluation of ABE8e- and ABE9-induced DNA and RNA mutations in Oryza sativa. Whole-genome sequencing analysis of plants transformed with four ABEs, including SpCas9n-TadA8e, SpCas9n-TadA9, SpCas9n-NG-TadA8e, and SpCas9n-NG-TadA9, reveal that ABEs harboring TadA9 lead to a higher number of off-target A-to-G (A>G) single-nucleotide variants (SNVs), and that those harboring CRISPR/SpCas9n-NG lead to a higher total number of off-target SNVs in the rice genome. An analysis of the T-DNAs carrying the ABEs indicates that the on-target mutations could be introduced before and/or after T-DNA integration into plant genomes, with more off-target A>G SNVs forming after the ABEs had integrated into the genome. Furthermore, we detect off-target A>G RNA mutations in plants with high expression of ABEs but not in plants with low expression of ABEs. The off-target A>G RNA mutations tend to cluster, while off-target A>G DNA mutations rarely clustered.
Conclusion: Our findings that Cas proteins, TadA variants, temporal expression of ABEs, and expression levels of ABEs contribute to ABE specificity in rice provide insight into the specificity of ABEs and suggest alternative ways to increase ABE specificity besides engineering TadA variants.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826654 | PMC |
http://dx.doi.org/10.1186/s13059-022-02618-w | DOI Listing |
J Med Chem
August 2025
Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
The histamine subtype 3 receptor (HR) is a G protein-coupled receptor involved in various central nervous system (CNS) disorders. We herein describe the identification and preclinical evaluation of two HR antagonists: compounds (H3-2406, = 2.87 nM) and (H3-2407, = 3.
View Article and Find Full Text PDFBioelectrochemistry
December 2025
Frank Reidy Research Center for Bioelectrics, Old Dominion University, Norfolk, VA 23508, USA. Electronic address:
Stimulation by pulsed electric fields (PEFs) normally follows PEF strength and weakens with distance from electrodes. Bipolar cancellation, caused by the electric field reversal, can offset this dependence. Remote focusing can be achieved by stimulation with nanosecond pulse packets that generate multiphasic, bipolar interference patterns near electrodes while preserving unipolar PEF at the remote target.
View Article and Find Full Text PDFCurr Pharm Biotechnol
May 2025
Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Menoufia, Egypt.
Background: Hesperidin is a flavonoid found in citrus fruits, particularly in the peel and pulp of oranges and lemons. By encapsulating drugs or bioactive compounds within NPs, it's possible to enhance their stability, solubility, and bioavailability. The current investigation aims to optimize hesperidin nanoparticles (Hes-NPs) and evaluate their hepatoprotective and antioxidant effects in paracetamol-intoxicated mice.
View Article and Find Full Text PDFFEMS Microbiol Ecol
May 2025
University of Thessaly, Department of Biochemistry and Biotechnology, Laboratory of Plant and Environmental Biotechnology, Larissa 41500, Greece.
Pesticides remain a cornerstone of modern agriculture. Despite their key role, it is well documented that pesticides can have considerable off-target effects on a range of organisms. The effects of pesticides on soil health, and more importantly on soil microbiota, are currently not well addressed at the regulatory level, despite cumulative evidence for the pivotal role of the soil microbiota on ecosystem functioning.
View Article and Find Full Text PDFMol Ther
May 2025
Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA; Department of Cell Biology, Duke University, Durham, NC 27710, USA; Center for Advanced Genomic Technologies, Duke University, Durham, NC 27708, USA. Electronic address:
Gene therapy stands at the forefront of medical innovation, offering unique potential to treat the underlying causes of genetic disorders and broadly enable regenerative medicine. However, unregulated production of therapeutic genes can lead to decreased clinical utility due to various complications. Thus, many technologies for controlled gene expression are under development, including regulated transgenes, modulation of endogenous genes to leverage native biological regulation, mapping and repurposing of transcriptional regulatory networks, and engineered systems that dynamically react to cell state changes.
View Article and Find Full Text PDF